Skip to content Skip to sidebar Skip to footer

Newsletter

Small Caps Stocks

Atomo Diagnostics investors are excited about their fair share from Lumos Diagnostics’ A$487m distribution deal

Wednesday 16 July 2025 was a great day for Atomo Diagnostics (ASX:AT1) investors as shares climbed up to 56% higher and closed 25% above the previous day's closing price. The catalyst was an A$487m deal signed by Lumos Diagnostics, one of Atomo's key business partners and investors believe the company will carve out some of…

ByNick SundichJuly 17, 2025

City Chic Collective (ASX:CCX): Is there any hope of a return to the glory days for the plus size fashion retailer?

City Chic Collective (ASX:CCX) shareholders who bought in late 2021 and have held the stock since would have seen just about all of their investment wiped out – with the share price down from $6 to less than 10c now. Such a decline would suggest the company had evolved into a shadow of its former self…

ByNick SundichJuly 17, 2025

BPM Minerals (ASX:BPM): Picking up unfinished business from AngloGold Ashanti and IGO

Last week was a big week for BPM Minerals (ASX:BPM). It sold its Claw Gold Project to Capricorn (ASX:CMM) for $1.5m and picked up the Forelands Gold Project from private vendors. Investors in BPM now have an exciting period ahead. Specifically, it is about to kick of an exploration program and could have a modest…

ByNick SundichJuly 15, 2025

Here Are 4 Dogs of the ASX that will Bounce Back With a Vengeance in FY26, and 4 That Won’t

Have you ever heard the term Dogs of the ASX? It can either allude to the worst stocks in the ASX generally, or perhaps the investment strategy of buying these worst performing shares at the start of a new year (either a calendar or financial year), thinking they will rebound. Many will be considering this strategy,…

ByNick SundichJuly 14, 2025

SDI (ASX:SDI): Will slow and steady win the race?

If you're looking for a stock that'll make you a fortune, SDI (ASX:SDI) might not be the best one for you. But if you just want a stock that has little downside risk, it might be more appropriate - but we can only say might. Given the record of dental stocks on the ASX, you might…

ByNick SundichJuly 11, 2025

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

Botanix Pharmaceuticals (ASX:BOT) crashed over 50% back on Tuesday after an update that left investors disappointed. A crash of this magnitude would suggest the FDA knocked back its drug or that it failed a clinical trial. With Botanix having commercialised its treatment, neither was the case, so it'd have to be a pretty bad sales update.…

ByNick SundichJuly 9, 2025

Here are Our 11 Top ASX Stocks to Buy in FY26: 1 From Each Sector!

It is a New Financial Year, so it's time to outline 11 Top ASX Stocks to Buy in FY26. Why 11 you might ask? Because 11 is the number of 'GICS' (Global Industry Classification Sectors) on the ASX, and we're picking one from each sector. Our 11 Top ASX Stocks to Buy in FY26! Energy: Ampol…

ByNick SundichJuly 7, 2025

Here Are 3 Small Cap ASX Stocks To Buy In FY26 And Why You Should Consider Them

As FY26 gets underway, we'll take a look at some of the top picks for the year ahead, and today we're looking at Small Cap ASX Stocks To Buy In FY26. When thinking about small-cap stocks on the ASX, many investors wonder whether there is an opportunity beyond high risk. In our view, growth lurks in…

ByUjjwal MaheshwariJuly 2, 2025

Here’s why it is a terrific time to look at ASX biotech small caps, and 4 worth considering for FY26

It's been a tough few years for ASX biotech small caps. Even in the last 18 months, the market recovered from post-COVID inflation small cap biotechs have been left behind. The ASX 200 Healthcare Index is down 7% in 2025 whilst the broader ASX 200 is up 4% (yes, even with the crash due to…

ByNick SundichJuly 1, 2025

Annual Recurring Revenue: Is it a useful metric or lipstick on a pig?

Annual Recurring Revenue (ARR), sometimes called Annualised Recurring Revenue, is a metric you'll hear some ASX small caps use. What does this term mean? Is it the same as actual revenue and is it a useful guide as to a business' performance? Annual Recurring Revenue vs (ordinary) revenue As you might except, there can be a…

ByNick SundichJune 27, 2025

the Kick-ass Multipurpose WordPress Theme

Small Caps Stocks

Atomo Diagnostics investors are excited about their fair share from Lumos Diagnostics’ A$487m distribution deal

City Chic Collective (ASX:CCX): Is there any hope of a return to the glory days for the plus size fashion retailer?

BPM Minerals (ASX:BPM): Picking up unfinished business from AngloGold Ashanti and IGO

Here Are 4 Dogs of the ASX that will Bounce Back With a Vengeance in FY26, and 4 That Won’t

SDI (ASX:SDI): Will slow and steady win the race?

Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?

Here are Our 11 Top ASX Stocks to Buy in FY26: 1 From Each Sector!

Here Are 3 Small Cap ASX Stocks To Buy In FY26 And Why You Should Consider Them

Here’s why it is a terrific time to look at ASX biotech small caps, and 4 worth considering for FY26

Annual Recurring Revenue: Is it a useful metric or lipstick on a pig?

Sectors

Quick Links

Learn

2020, the Golden Year

Investing in the Year of the Rat

Market trouble spots to avoid in 2020

Small Caps Stocks

Sectors

Quick Links

Learn

Add Your Heading Text Here